Integra Lifesciences Q4 Adj. EPS $0.83 Beats $0.80 Estimate, Sales $434.925M Beat $429.621M Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings BeatsNews
Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.80 by 3.75 percent. This is a 14.43 percent decrease over earnings of $0.97 per share from
Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.80 by 3.75 percent. This is a 14.43 percent decrease over earnings of $0.97 per share from the same period last year. The company reported quarterly sales of $434.925 million which beat the analyst consensus estimate of $429.621 million by 1.23 percent. This is a 1.74 percent decrease over sales of $442.645 million the same period last year.